Search Results
- < Prev
1 of 1
- Next >
News Releases
-
Apr 10, 2013, 08:00 ET
Actavis Reaches Agreements with Valeant to Launch Generic Versions of Ziana® and Zyclara®
Actavis, Inc. (NYSE: ACT), and Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX), today announced that Actavis has reached settlement agreements with Medicis Pharmaceutical Corporation, a subsidiary of Valeant Pharmaceuticals International, Inc., resolving outstanding patent...
More news about: Actavis, Inc. , Valeant Pharmaceuticals International, Inc. , Medicis Pharmaceutical Corporation
- < Prev
1 of 1
- Next >
Modify your Search
 |
Quickly search for PR Newswire releases by adding our plugin to your browser search |